{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:09:40Z","timestamp":1768039780858,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011404","name":"Indivior PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jsat.2021.108349","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:34:00Z","timestamp":1614972840000},"page":"108349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Use of non\u2013prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration"],"prefix":"10.1016","volume":"127","author":[{"given":"Jan","family":"Gryczynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjalee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura B.","family":"Monico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"DeVeaugh-Geiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Chilcoat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108349_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsat.2016.08.002","article-title":"Non-prescribed buprenorphine in New York City: Motivations for use, practices of diversion, and experiences of stigma","volume":"70","author":"Allen","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108349_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2016.11.032","article-title":"Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses","volume":"171","author":"Bi-Mohammed","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.jsat.2021.108349_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073110518782933","article-title":"Our ethical obligation to treat opioid use disorder in prisons: A patient and physician\u2019s perspective","volume":"46","author":"Bone","year":"2018","journal-title":"The Journal of Law, Medicine & Ethics"},{"key":"10.1016\/j.jsat.2021.108349_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addbeh.2018.02.024","article-title":"Criminal justice continuum for opioid users at risk of overdose","volume":"86","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2007.11.019","article-title":"Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention","volume":"19","author":"Bruce","year":"2008","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2021.108349_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: Motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108349_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"18","key":"10.1016\/j.jsat.2021.108349_bb0045","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting patterns of prescription opioid and heroin abuse in the United States","volume":"373","author":"Cicero","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2021.108349_bb0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: A retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2021.108349_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008-2013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"Buprenorphine pharmacology review: Update on transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2021.108349_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2105\/AJPH.2018.304852","article-title":"Criminal justice barriers to treatment of opioid use disorders in the United States: The need for public health advocacy","volume":"109","author":"Csete","year":"2019","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.jsat.2021.108349_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2021.108349_bb0075","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"40","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10610-017-9349-y","article-title":"Current and promising pharmacotherapies for substance use disorders among justice-involved populations","volume":"24","author":"Farabee","year":"2018","journal-title":"European Journal on Criminal Policy and Research"},{"issue":"4","key":"10.1016\/j.jsat.2021.108349_bb0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jurban\/jth147","article-title":"Jail management of arrestees\/inmates enrolled in community methadone maintenance programs","volume":"81","author":"Fiscella","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1078345820917356","article-title":"Drug- and alcohol-associated deaths in U.S. Jails","volume":"26","author":"Fiscella","year":"2020","journal-title":"Journal of Correctional Health Care"},{"issue":"12","key":"10.1016\/j.jsat.2021.108349_bb0100","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jsat.2021.108349_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108349_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","article-title":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","volume":"172","author":"Gordon","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2021.108349_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2021.108349_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2021.108349_bb0130","unstructured":"Hedegaard, H., Minino, A. M., & Warner, M. (2018). Drug overdose deaths in the United States, 1999-2017. NCHS data brief(329), 1\u20138. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30500323."},{"issue":"1\u20133","key":"10.1016\/j.jsat.2021.108349_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","article-title":"A conceptual model for understanding post-release opioid-related overdose risk","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108349_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/09581590400027478","article-title":"Harm reduction in prisons: A \u201crights based analysis\u201d","volume":"14","author":"Kerr","year":"2004","journal-title":"Critical Public Health"},{"key":"10.1016\/j.jsat.2021.108349_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinfrocement","volume":"87","author":"Koob","year":"2020","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: A study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"The American Journal of Forensic Medicine and Pathology"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2021.108349_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0376-8716(85)90067-5","article-title":"Buprenorphine","volume":"14","author":"Lewis","year":"1985","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108349_bb0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2021.108349_bb0170","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108349_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.jsat.2021.108349_bb0180","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2021.108349_bb0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Mitchell","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2021.108349_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108267","article-title":"Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration","volume":"123","author":"Monico","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108349_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108349_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108349_bb0205","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"10.1016\/j.jsat.2021.108349_bb0210","series-title":"NIDA research monograph 121","article-title":"Buprenorphine: An alternative treatment for opioid dependence","author":"National Institute on Drug Abuse (NIDA)","year":"1992"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108349_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108349_bb0220","doi-asserted-by":"crossref","unstructured":"Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep, 67(5152), 1419\u20131427. 10.15585\/mmwr.mm675152e1.","DOI":"10.15585\/mmwr.mm675152e1"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7129","key":"10.1016\/j.jsat.2021.108349_bb0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","article-title":"Mortality from overdose among injecting drug users recently released from prison: Database linkage study","volume":"316","author":"Seaman","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jsat.2021.108349_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1016\/j.jsat.2021.108349_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17449200902880482","article-title":"Exploring prison buprenorphine misuse in the United Kingdom: A qualitative study of former prisoners","volume":"5","author":"Tompkins","year":"2009","journal-title":"International Journal of Prisoner Health"},{"key":"10.1016\/j.jsat.2021.108349_bb0245","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenoprhine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dar.12317","article-title":"The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film","volume":"35","author":"White","year":"2016","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.jsat.2021.108349_bb0255","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2021.108349_bb0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:57Z","timestamp":1760039637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"alternative-id":["S0740547221000751"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108349","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of non\u2013prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108349"}}